USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Adult Hemoglobinopathy Testing Market By Variant Type (Variant A2, and Variant F), By Test Type (HPLC Test, Mass Spectrometry, and Hemoglobin Electrophoresis), End User (Hospitals, Reference Laboratories, and Academic & Medical Institutes): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2026

Covid-19

Global Adult Hemoglobinopathy Testing Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[197+ Pages Report] Over the projected period, the adult hemoglobinopathy testing market is projected to develop rapidly. The global adult hemoglobinopathy testing market was worth USD 330 Million in 2020 and is expected to be worth about USD 430 Million by 2026, expanding at a CAGR of 3.9%.

logoMarket Overview

Hemoglobinopathy is caused by genetic abnormalities and anemia. Structure defects in the hemoglobin molecule decreased synthesis of one of the two subunits of the hemoglobin molecule, and pathological interactions of normally usual subunits both contribute to the development of irregular hemoglobin. There are two types of disorders: extreme and moderate. The hemoglobin (Hb) molecule is either decreased in development or has its structure altered as a result of these mutations. The existence of variant hemoglobin in red blood cells causes hemoglobinopathy disease. The global adult hemoglobinopathy testing market is expected to grow at a rapid pace as a result of a number of government-provided health services, such as payment programs for therapies and diagnostic tests, as well as the care of current hemoglobinopathy patients. NGO's are now working hard to develop advanced research techniques for hemoglobinopathy diagnosis. Global adult hemoglobinopathy is also on the rise due to factors such as NGO and government cooperation to create more innovative diagnostic methods, the rapid expansion of POC diagnosis methods, and low-cost therapies.

logoIndustry Growth Factors

The adult hemoglobinopathy testing market is anticipated to rise over the forecast period owing to increasing incidences of sickle cell disease, thalassemia, and other hemoglobinopathies. The industry is also influenced by policymakers' increasing support for measuring and controlling diseases related to blood, as well as advances in technology. During the forecast period, the developing region is expected to provide growth opportunities for the industry. The global adult hemoglobinopathy testing market is expected to face some challenges that could limit its expansion. Adult hemoglobinopathy research market development is likely to be hampered by a lack of knowledge about hemoglobinopathy disorders and testing in various developing and underdeveloped emerging economies. The market's development may be hampered by a lack of innovative screening technology procedures such as genetic testing, the sophistication of hemoglobinopathy tests, and the disease's rising prevalence.

logo COVID-19 Impact

COVID-19 began in December of 2019 in Wuhan, China, and has quickly spread around the world since then. Given the rapid spread of the pandemic and the shortage of research, proper treatment and management of Coronavirus (COVID-19) infection in patients affected by adult Hematological testing could be difficult, particularly in some countries. Various programs are putting forward attempts at this critical point to generate papers with indications for the health treatment of these patients. Adult hemoglobinopathy research firms should take care of this opportunity. COVID-19 has also unleashed a slew of new opportunities for several private firms to join the market in order to satisfy the significant challenge. Apart from that, a programme that calculates hemoglobinopathy testings automatically is gaining popularity as an alternative to traditional studies. In addition, owing to the widespread outbreak of coronavirus disease (COVID-19) and the absence of an appropriate vaccine or cure, Adult hemoglobinopathy testing research is being used to measure the effectiveness of existing medications as a potential treatment, which is boosting market development. The expansion of the Adult hemoglobinopathy testing research industry has been aided by the COVID-19 pandemic. It's used to find potential COVID-19 drug candidates and to assess the cell model using Adult hemoglobinopathy testing. As a result, demand for Adult hemoglobinopathy testing research is projected to increase in 2020, boosting market share.

logoGlobal Adult Hemoglobinopathy Testing Market: Segmentation

The global adult hemoglobinopathy testing market is bifurcated into its Variant Type, Test Type, distribution channel, and regions. Based on the variant type, the global market is divided into Variant A2, and Variant F. Based on Test Type, the market is bifurcated into HPLC test, mass spectrometry, and hemoglobin electrophoresis. Based on the End User, the market is segmented into reference laboratories, hospitals, and academic & medical institutes. Geographically, the global adult hemoglobinopathy testing market is diversified into North America, Asia-Pacific, Europe, Middle East & Africa, and Latin America.

logoGlobal Adult Hemoglobinopathy Testing Market: Regional Analysis

The global adult hemoglobinopathy testing market is dominated by Europe, which is predicted to continue to do so over the forecast period. Because of the increasing prevalence of hemoglobinopathy in countries like India and China, Asia Pacific is projected to rise faster than the rest of the world during the forecast period. Sickle Cell Anemia is a global health problem that is most prevalent in African and Sub-Asian countries, according to the World Health Organization. A significant number of people from the affected areas are migrating to Europe and North America, resulting in an increase in the number of new cases of hemoglobinopathy disorders being diagnosed. The adult hemoglobinopathy testing market is expected to boom in northern and central Europe, especially Germany, as a result of increased migration. Similarly, as a result of increased migration from Asia, the number of hemoglobinopathy cases observed in North America has increased, fueling the hemoglobinopathy testing market over the projected era. In the face of rising hemoglobinopathy genotypes, policymakers have implemented a variety of public health initiatives, such as genetic testing, screening services, and counseling, which will continue to propel the global adult hemoglobinopathy testing market within the forecast period.

logoGlobal Adult Hemoglobinopathy Testing Market: Competitive Players

Some of the key players in the adult hemoglobinopathy testing market are Chromsystems Instruments & Chemicals GmbH, PerkinElmer Inc., CapitalBio Technology Inc., Bio-Rad Laboratories, Inc., BioMedomics, Inc., Streck, Inc., Thermo Fisher Scientific Inc., Trinity Biotech, Baxter, and Bluebird Bio among others. 

logoThis report segments the adult hemoglobinopathy testing market as follows:

logo By Variant Type Segmentation Analysis

  • Variant A2
  • Variant F

logo By Test Type Segmentation Analysis

  • HPLC Test
  • Mass Spectrometry
  • Hemoglobin Electrophoresis

logo By End User Segmentation Analysis

  • Hospitals
  • Reference Laboratories
  • Academic & Medical Institutes

logoGlobal Adult Hemoglobinopathy Testing Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Covid-19

Adult Hemoglobinopathy Testing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer Inc.
  • CapitalBio Technology Inc.
  • Bio-Rad Laboratories Inc.
  • BioMedomics Inc.
  • Streck Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech
  • Baxter
  • Bluebird Bio

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Adult Hemoglobinopathy Testing Market.
According to Facts and Factors research report, the global Adult Hemoglobinopathy Testing Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Adult Hemoglobinopathy Testing Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Adult Hemoglobinopathy Testing Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Adult Hemoglobinopathy Testing Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Hirudin Market Report 2022 – 2028

[227+ Pages Report] According to the report published by Facts Factors, the global hirudin market size was worth around USD 3908.9 million in 2021 and is predicted to grow to around USD 4575.60 million by 2028 with a compound annual growth rate (CAGR) of roughly 2.7% between 2022 and 2028. The rep...

Published Date : 27-Sep-2022 | | Category : | Pages : 227 | Format : Read more

Inquiry for Buying Request Sample
report img

Hirudin Market Report 2022 – 2028

[227+ Pages Report] According to the report published by Facts Factors, the global hirudin market size was worth around USD 3908.9 million in 2021 and is predicted to grow to around USD 4575.60 million by 2028 with a compound annual growth rate (CAGR) of roughly 2.7% between 2022 and 2028. The rep...

Published Date : 27-Sep-2022 | | Category : | Pages : 227 | Format : Read more

Inquiry for Buying Request Sample